PENTA Foundation   Report issue

Foundation Phase 1 Phase 2 Phase 3
Founded: Padova Italy (2004)

Organization Overview

First Clinical Trial
2004
NCT00039741
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

PENTA Foundation